Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00B5SGVL29 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.44 -10.00% 3.96 320,484 09:40:45
Bid Price Offer Price High Price Low Price Open Price
3.66 4.26 4.40 3.96 4.35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 11.62 -8.88 -0.70 46
Last Trade Time Trade Type Trade Size Trade Price Currency
10:46:43 O 24,390 4.10 GBX

Tissue Regenix (TRX) Latest News

More Tissue Regenix News
Tissue Regenix Takeover Rumours

Tissue Regenix (TRX) Share Charts

1 Year Tissue Regenix Chart

1 Year Tissue Regenix Chart

1 Month Tissue Regenix Chart

1 Month Tissue Regenix Chart

Intraday Tissue Regenix Chart

Intraday Tissue Regenix Chart

Tissue Regenix (TRX) Discussions and Chat

Tissue Regenix Forums and Chat

Date Time Title Posts
16/7/201916:31Tissue Regenix delivering practical solutions to real clinical issues2,114
06/1/201921:18Torex - an insiders tale25
24/5/201610:30Third time lucky6,918
29/6/201321:26TOREX 2007 - THE TILLS RING AT LAST8
24/9/201210:10Torex Retailing8

Add a New Thread

Tissue Regenix (TRX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
09:46:444.1024,390999.99O
09:42:094.2610,000426.00O
09:16:223.8189434.06O
08:47:534.115,000205.50O
08:47:274.1120,000822.00O
View all Tissue Regenix trades in real-time

Tissue Regenix (TRX) Top Chat Posts

DateSubject
23/7/2019
09:20
Tissue Regenix Daily Update: Tissue Regenix Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 4.40p.
Tissue Regenix Group Plc has a 4 week average price of 3.20p and a 12 week average price of 3.20p.
The 1 year high share price is 10.75p while the 1 year low share price is currently 3.20p.
There are currently 1,171,730,823 shares in issue and the average daily traded volume is 315,186 shares. The market capitalisation of Tissue Regenix Group Plc is £46,400,540.59.
09/7/2019
10:27
andrewbaker: Based on the company and what it is doing, the share price is an anomoly; which I believe is caused by Woodford having to sell shares to raise cash. Given this situation, now is the time to add or take a position, as the price is way too low for the potential and, in my view, likely future growth.
25/4/2019
20:11
channel pirate: Well the positive Trading Report and progress reports this year that seemed to have lifted the share price a little looks to not have held the gains that followed those RNS's. Seen this over on the LSE bb (courtesy of Sandhopper) today, so looks like pi's are still buying albeit not in any great volumes :- "So MM's put the BUY price up by 0.25p today. I took a few more today - and 99.9% sure that the overall totals showing sold / buy are not correct. It's showing 92729 sold with only 16619 bought. My reckoning is that sells are 32865 and buys are76483. Crazy share price really as RNS's are telling us the company is making more money now than at any time before, yet the share price is not far off a 12 month low !!"
29/10/2018
17:42
robste: Today, like many other days recently, TRX was showing as over 6% down without the volume of sales to even remotely justify such a fall. Then, when the market closed, it suddenly reverted to show no changed in the share price. I've noticed this happening with other shares in my portfolio too, mostly AIM or smaller companies. Can anyone shed any light on why prices can temporarily show large drops like this, only to revert to its correct price once the market closes?
07/6/2018
14:43
channel pirate: Quiet on here whilst we all wait for some good news to be announced. The 16988 shares showing as a "sell" at 10.975p today is actually my "BUY". Sold some of these a little while back and bought them back today £100 cheaper, not a lot I know, but sold a different share yesterday for £800 profit, so thought I would put it toward rounding up my holding here. C'mon Mr Couldwell, an update might just get the share price moving in the right direction again.
26/2/2018
07:17
channel pirate: 2 X RNS's today !! Let's hope we get some positive share price lifting results on 19th March then: 26/02/2018 7:01am UK Regulatory (RNS & others) Tissue Regenix (LSE:TRX) Intraday Stock Chart Today : Monday 26 February 2018 Click Here for more Tissue Regenix Charts. TIDMTRX RNS Number : 8568F Tissue Regenix Group PLC 26 February 2018 Tissue Regenix Group plc Notice of Results Leeds, 26 February 2018 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces it will release its unaudited preliminary results for the year ended 31 December 2017 on Monday 19 March. Further information regarding an analyst call will follow in due course. For more Information: Tissue Regenix Group plc Tel: 0330 Caitlin Pearson Head of Communications 430 3073 / 07920272 441 ---------------------------------------- ------------ Jefferies International Ltd Tel: 020 Simon Hardy / Christopher Binks 7029 8000 ---------------------------------------- ------------ FTI Consulting Tel: 0203 Brett Pollard / Mo Noonan/ Rob Winder 727 1000
25/8/2017
20:52
channel pirate: Well the company are good at manufacturing tissue to repair / heal wounds etc, so maybe they ought to manufacture a positive RNS that will repair the share price which has been severely wounded over the past few months !!
11/8/2017
15:05
andrewbaker: Adding to and following on from post 1934 in June, it's heartening to know that even a business that's not blessed with the best management, can become compelling when the product is really good and the share price way too low. What we really need is better figures, and better management; then this can really go. I'd buy more, but I'm already loaded to the gills, and can't destabilise my portfolio by doing so: so ... you guys drink your fill, and enjoy what should be, better late that never, a big rise northwards (and more northwards than before, too). ... Couldn't resist it: bought another 15,000 at 13.95p. I'm holding a heck of a lot more, so ok for this top-up, IMHO. lol. :)
22/6/2017
09:52
channel pirate: With the share price having lost just over 35.36% in the last 6 months, then we could do with some good supporting news right now, or like "yesterday" and not "tomorrow". I have built a nice size holding during these past 6 months, but will not be panic selling or adding more until we get some positive news from the company.
29/5/2017
07:49
channel pirate: Morning bamboo2, Guessing, then the new Holdings Company has been inaugurated to acquire acquisitions the Main Company has in their sights as being beneficial to the Main Company – hence the recent RNS regarding CellRight Technologies, LLC ("CellRight"). To me then this indicates the Company is getting “stronger̶1; all round and is expanding, generating more income etc, both of which has not yet been updated to the market. I would expect the large shareholders (Invesco, Woodford etc) are already briefed what is happening, especially with the share price languishing at the present low price, which must have knocked millions off the value of their holdings. I’m looking forward to the Prelims, and let’s hope it reassures us small pi’s also that we have “boarded the right train”.
27/7/2016
07:08
multibagger: Hi Swiss Paul, Some very valid and searching questions. The biotech/healthcare product market is a very complex one due to various procurement and payment schemes/methods. In the UK, the NHS is a slow adopter and constrained by cost.The US is a much higher cost healthcare system and if TRX finds traction there, then there will be an uplift in share price. Though I keep an eye on TRX, I am not of the view that the share price will move upwards fast and not invested currently. I'm not a fan of either Odell or Samuels having met them both in Leeds at the AGM a few years ago, when I was the only shareholder present ! I'm not convinced about their their tech pipeline either, as regenerative medicine is moving a lot quicker than TRX are. I sold out not long after. My approach to biotech investing has changed and now largely go for funds....I hold AXA Framlington Biotech though I made good money from SCLP, SUMM and SAR in the past.Cyprotex (CRX) is moving in the right direction and their R&D product delivery and commercialisation is much more attractive - I pointed it out here when it was about 60p on this board - now about 135p. I hope TRX comes good for all holders - but my take is that investors may have a fairly long wait. Good luck all :)
Tissue Regenix share price data is direct from the London Stock Exchange
Your Recent History
LSE
TRX
Tissue Reg..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190723 11:08:25